Celularity Inc. Proceeds from Warrant Exercises
Celularity Inc. (CELU) reported Proceeds from Warrant Exercises of $2.46 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2025-11-14
- Celularity Inc. proceeds from warrant exercises for the quarter ending 2022-12-31 was $1.00K.
- Celularity Inc. proceeds from warrant exercises for the quarter ending 2022-09-30 was $1.00K.
- Celularity Inc. proceeds from warrant exercises for the quarter ending 2022-06-30 was $4.00K.
- Celularity Inc. proceeds from warrant exercises for the quarter ending 2022-03-31 was $46.48M.
- Celularity Inc. proceeds from warrant exercises for fiscal 2022 was $46.49M.
| Period end | Proceeds from Warrant Exercises | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $2.46M 10-Q · filed 2025-11-14 | ||||
| 2023-07-31 | $3.00M 10-Q · filed 2025-11-14 | ||||
| 2023-04-10 | $6.00M 10-Q · filed 2025-11-14 | ||||
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $2.00K derived: sum of 2 quarters · filed 2024-01-03 | $6.00K derived: sum of 3 quarters · filed 2024-01-03 | $46.49M 10-K · filed 2023-03-31 | |
| 2022-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-01-03 | $5.00K derived: sum of 2 quarters · filed 2024-01-03 | $46.49M 10-Q · filed 2024-01-03 | ||
| 2022-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $46.49M 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $46.48M 10-Q · filed 2023-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |